Influential Analyst Rating Changes: Alliqua BioMedical, Inc. (ALQA), U.S. Global Investors, Inc. (GROW)

Alliqua BioMedical, Inc. (NASDAQ:ALQA) tinted gains of +7.54% (+0.15 points) to US$2.14. The volume of 3.95 Million shares climbed up over an trading activity of 1.41 Million shares. EPS ratio determined by looking at last 12 month figures is -6.77. Over the same time span, the stock marked US$5.24 as its best level and the lowest price reached was US$1.55. The corporation has a market cap of US$11.75 Million.

Alliqua BioMedical, Inc. (NASDAQ:ALQA)’s earnings per share has been growing at a -1.7 percent rate over the past 5 year when average revenue increase was noted as 73.9 percent. The return on equity ratio or ROE stands at -164.8 percent while most common profitability ratio return on investment (ROI) was -154.4 percent. The company’s institutional ownership is monitored at 22.1 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 50.1 percent gross margin.

U.S. Global Investors, Inc. (NASDAQ:GROW) is worth US$19.42 Million and has recently risen 7.32% to US$1.32. The latest exchange of 0.07 Million shares is below its average trading activity of 78.49 Million shares. The day began at US$0 but the price moved to US$0 at one point during the trading and finally capitulating to a session high of US$0. The stock tapped a 52-week high of US$5.41 while the mean 12-month price target for the shares is US$0.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 0.82, and a price to sales ratio of 3.24. For the past 5 years, the company’s revenue has grown -18.4%, while the company’s earnings per share has grown 91%. With an institutional ownership near 25.9%, it carries an earnings per share ratio of -0.12.